We are delighted to speak with Dr Robin Foà, one of our Editorial Board members for touchREVIEWS in Oncology & Haematology, to discuss the sustainability and accessibility of CAR-T Cell Therapy as well as the challenges associated with this treatment.
Questions
- Could you give us a brief overview of the current approval status of CAR-T cell therapy? (00:15-02:21)
- At present, is CAR-T cell therapy worth the high direct and indirect costs? (02:21-04:45)
- How can we reduce the costs associated with CAR-T cell therapy? (04:45-08:12)
- What are the challenges associated with the availability and accessibility of CAR-T cell therapy? (08:12-09:55)
- How can we improve efficacy and safety outcomes with these therapies? (09:55-12:11)
- How do you see the use of CAR-T cell therapy evolving in the coming years? (12:11-14:50)
Speaker Disclosure: Robin Foà has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
